Skip to main content
Viking Therapeutics, Inc. logo

Viking Therapeutics, Inc. — Investor Relations & Filings

Ticker · VKTX ISIN · US92686J1060 LEI · 529900IVC72YPFA25M37 US Professional, scientific and technical activities
Open in API
Filings indexed 608 across all filing types
Latest filing 2025-04-23 Regulatory Filings
Country US United States of America
Listing US VKTX

About Viking Therapeutics, Inc.

https://vikingtherapeutics.com/

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel therapies for patients suffering from metabolic and endocrine disorders. The company's pipeline is centered on small molecule drug candidates designed to address these conditions.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions Item 2.02 "Results of Operations and Financial Condition" and states that a press release reporting financial results for the first quarter ended March 31, 2025, is furnished as an exhibit. The document itself does not contain detailed financial statements or substantive financial data but rather references a press release. The length is 3870 characters, which is relatively short and consistent with a current report filing rather than a full financial report. According to the rules, such a document is best classified as a Regulatory Filing (RNS) because it is a current report announcing financial results but does not contain the full financial report or detailed analysis itself.
2025-04-23 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce significant events. The content specifically details a change in the company's independent registered public accounting firm, including the resignation of the previous auditor and appointment of a new auditor. It includes disclosures about the audit reports, disagreements, and reportable events, as well as a letter from the former auditor. This type of filing is not a full Annual Report (10-K) or an Audit Report (AR) itself, but rather a regulatory announcement about changes in the auditor. The document is over 7,000 characters and contains detailed information about the auditor change, which is typical for an 8-K filing. According to the classification rules, such filings fall under Regulatory Filings (RNS) as they do not fit other specific categories and are regulatory announcements about corporate events.
2025-04-23 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-04-23 English
Regulatory Filings 2025
Regulatory Filings
2025-04-21 English
4
Director's Dealing
2025-04-15 English
4/A
Director's Dealing
2025-04-09 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.